In fact, a large fraction of ER binding sites (and other nuclear hormone binding sites) in the mammalian genome do not conform to the consensus motif [11,16,17]. binding these sites, estrogen and ER directly participate in the DNA loop formation required for CSR. We further suggest that estrogen regulates immunoglobulin expression patterns and can thereby influence (S)-Reticuline life-and-death outcomes of contamination, hypersensitivity, and autoimmune disease. == Estrogen, a nuclear hormone == Estrogen is usually a nuclear hormone that is best known for its influence on reproductive organs, but is also critical for the development and function of cardiovascular, skeletal, nervous, and immune systems [18]. Estrogen (S)-Reticuline signals at both intra- and extra-nuclear sites [9], but we will focus here on its intra-nuclear functions. Estrogen is usually a ligand for estrogen receptors (ER) and , which are type I nuclear hormone receptors with DNA binding sites throughout the mammalian genome [911]. The receptors are frequently associated with promoters, enhancers, DNA loops, and complex protein-DNA interactions [1113]. Nuclear hormone receptors have multiple, structurally unique domains including an N-terminal domain name with activation function (AF-1), a central DNA-binding domain name (DBD), and a carboxyl-terminal ligand binding domain name (LBD) with ligand-dependent function (AF-2). ER binds DNA best as a dimer, but monomer binding is also observed [14,15]. Receptor functions are regulated by ligand binding (e.g. with estradiol or Rabbit Polyclonal to TSPO tamoxifen), DNA targets, and interactions with other transcription factors [11]. Typically, two ER monomers bind cooperatively with a consensus ERE (GGTCANNNTGACC), but binding is usually promiscuous and ER can also bind non-consensus sites, in some cases tethered by other proteins. In fact, a large portion of ER binding sites (and other nuclear hormone binding sites) in the mammalian genome do not conform to the consensus motif [11,16,17]. Ligand binding directly influences transcriptional regulation by altering ER-DNA conformations and associations with other transcription factors. For example, research using an estrogen-responsive pS2 promoter showed (S)-Reticuline that unliganded ER (apo ER) could bind and repress transcription, and that the addition of estrogen resulted in conformational changes that supported RNA Polymerase II (RNA Pol II) recruitment and improved gene expression [1821]. Outcomes of interactions between ER and other transcription factors may be enhancing or antagonistic, as molecules may synergize or compete for ligands and DNA binding sites [22]. == Benefits and risks of high estrogen levels == In mice and humans, immune responses of males and females differ. For example, studies of rodents and humans show sex-specific differences in antibody isotype expression patterns in sera. Overall, females tend to express higher levels of immunoglobulins compared to males (often including IgM, IgG1, IgG2, and/or IgE [23,24]). In small animal studies, the treatment of males with estrogen was shown to up-regulate immunoglobulin levels and antigen-specific antibody-producing cells [25,26]. In humans, estrogen levels correlated with IgG responses toward an influenza computer virus vaccine [27]. Inex vivocultures of mouse splenocytes, estrogen increased levels of IgM and IgE [28,29]. Differences in immunoglobulin levels between the sexes help explain, at least in part, why adult females gain better control of certain infectious diseases compared to males [30,31]. This benefit for females is not without risk; females suffer more than males from hyper-immune responses toward typically harmless substances or self-antigens [3236]. Consequences can include life-threatening episodes of allergic asthma or systemic lupus erythematosus (SLE, lupus), particularly among pregnant women [3743] in whom estrogen levels can soar to >6,000 pg/ml (S)-Reticuline (as compared to the 100 pg/ml level common of an adult male)[44,45]. In a mouse model,.